Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer

Biochemical and Biophysical Research Communications

Volumn 314, Issue 1, 2004, Pages 223-228

  Li, Qing Lin ^a   Kim, Hye Ryeon ^a   Kim, Wun Jae ^a   Choi, Joong Kook ^a   Hee Lee, Yong ^a   Kim, Hwan Mook ^b   Shan Li, Long ^c   Kim, Hoguen ^c   Chang, Joon ^c   Ito, Yoshiaki ^d   Youl Lee, Kwang ^a   Bae, Suk Chul ^a  

^a Chungbuk National University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

Author keywords

Lung cancer; Methylation; RUNX3; TGF ; Transcription

Indexed keywords

DNA; TRANSCRIPTION FACTOR RUNX3;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CPG ISLAND; DISEASE ASSOCIATION; DISEASE COURSE; DNA METHYLATION; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LUNG CANCER; LUNG PARENCHYMA; PRIORITY JOURNAL;

EID: 9144223364     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.12.079     Document Type: Article

References (21)

1. Nomoto S., Haruki N., Tatematsu Y., Konishi H., Mitsudomi T., Takahashi T., Takahashi T. Frequent allelic imbalance suggests involvement of a tumor suppressor gene at 1p36 in the pathogenesis of human lung cancers. Genes Chromosomes Cancer. 28:2000;342-346.
2. Schwab M., Praml C., Amler L.C. Genomic instability in 1p and human malignancies. Genes Chromosomes Cancer. 16:1996;211-229.
3. Tanaka K., Yanoshita R., Konishi M., Oshimura M., Maeda Y., Mori T., Miyaki M. Suppression of tumourigenicity in human colon carcinoma cells by introduction of normal chromosome 1p36 region. Oncogene. 8:1993;2253-2258.
4. Herzog C.R., Wang Y., You M. Allelic loss of distal chromosome 4 in mouse lung tumors localize a putative tumor suppressor gene to a region homologous with human chromosome 1p36. Oncogene. 11:1995;1811-1815.
5. Lund A.H., van Lohuizen M. RUNX: a trilogy of cancer genes. Cancer Cell. 1:2002;213-215.
6. Look A.T. Oncogenic transcription factors in the human acute leukemias. Science. 278:1997;1059-1064.
7. Mundlos S., Otto F., Mundlos C., Mulliken J.B., Aylsworth A.S., Albright S., Lindhout D., Cole W.G., Henn W., Knoll J.H., Owen M.J., Mertelsmann R., Zabel B.U., Olsen B.R. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell. 89:1997;773-779.
8. Bae S.C., Takahashi E., Zhang Y.W., Ogawa E., Shigesada K., Namba Y., Satake M., Ito Y. Cloning, mapping and expression of PEBP2 alpha C, a third gene encoding the mammalian Runt domain. Gene. 159:1995;245-248.
9. Li Q.L., Ito K., Sakakura C., Fukamachi H., Inoue K., Chi X.Z., Lee K.Y., Nomura S., Lee C.W., Han S.B., Kim H.M., Kim W.J., Yamamoto H., Yamashita N., Yano T., Ikeda T., Itohara S., Inazawa J., Abe T., Hagiwara A., Yamagishi H., Ooe A., Kaneda A., Sugimura T., Ushijima T., Bae S.C., Ito Y. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell. 109:2002;113-124.
10. Bangsow C., Rubins N., Glusman G., Bernstein Y., Negreanu V., Goldenberg D., Lotem J., Ben Asher E., Lancet D., Levanon D., Groner Y. The RUNX3 gene - sequence, structure and regulated expression. Gene. 279:2001;221-232.
11. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., Baylin S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA. 93:1996;9821-9826.
12. Jones P.A., Laird P.W. Cancer epigenetics comes of age. Nat. Genet. 21:1999;163-167.
13. Baylin S.B., Esteller M., Rountree M.R., Bachman K.E., Schuebel K., Herman J.G. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum. Mol. Genet. 10:2001;687-692.
14. Cameron E.E., Bachman K.E., Myohanen S., Herman J.G., Baylin S.B. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat. Genet. 21:1999;103-107.
15. Konduri S.D., Srivenugopal K.S., Yanamandra N., Dinh D.H., Olivero W.C., Gujrati M., Foster D.C., Kisiel W., Ali-Osman F., Kondraganti S., Lakka S.S., Rao J.S. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells. Oncogene. 22:2003;4509-4516.
16. Ohtani-Fujita N., Dryja T.P., Rapaport J.M., Fujita T., Matsumura S., Ozasa K., Watanabe Y., Hayashi K., Maeda K., Kinoshita S., Matsumura T., Ohnishi Y., Hotta Y., Takahashi R., Kato M.V., Ishizaki K., Sasaki M.S., Horsthemke B., Minoda K., Sakai T. Hypermethylation in the retinoblastoma gene is associated with unilateral, sporadic retinoblastoma. Cancer Genet. Cytogenet. 98:1997;43-49.
17. Massague J., Blain S.W., Lo R.S. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell. 103:2000;295-309.
18. Hanai J., Chen L.F., Kanno T., Ohtani-Fujita N., Kim W.Y., Guo W.H., Imamura T., Ishidou Y., Fukuchi M., Shi M.J., Stavnezer J., Kawabata M., Miyazono K., Ito Y. Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter. J. Biol. Chem. 274:1999;31577-31582.
19. Ito Y., Miyazono K. RUNX transcription factors as key targets of TGF-beta superfamily signaling. Curr. Opin. Genet. Dev. 13:2003;43-47.
20. Derynck R., Akhurst R.J., Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat. Genet. 29:2001;117-129.
21. Tang B., Bottinger E.P., Jakowlew S.B., Bagnall K.M., Mariano J., Anver M.R., Letterio J.J., Wakefield L.M. Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency. Nat. Med. 4:1998;802-807.